Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus (vol 53, pg 891, 2016)

被引：2
|
作者：
Ning, Hui [1 ,2 ]
Tao, Hong [2 ]
Weng, Zhanping [2 ]
Zhao, Xingbo [1 ]
机构：
[1] Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynaecol, Jinan 250012, Shandong, Peoples R China
[2] Qingdao Municipal Hosp, Dept Obstet & Gynaecol, Qingdao 266000, Shandong, Peoples R China
来源：
ACTA DIABETOLOGICA | 2018年 / 55卷 / 10期
关键词：
D O I：
10.1007/s00592-018-1177-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The title “Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus” should be replaced by “Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus”.
引用
收藏
页码：1089 / 1089
页数：1
相关论文
共 50 条
  • [41] Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury
    Obajdin, Jana
    Cotter, Mabel
    Snelling, Sara
    Dremier, Sarah
    De Ron, Pierrette
    Fleurance, Renaud
    Valentin, Jean-Pierre
    da Costa, Andre Nogueira
    Gryshkova, Vitalina
    TOXICOLOGICAL SCIENCES, 2018, 166 (02) : 441 - 450
  • [42] Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naive patients
    Harraz, Ahmed M.
    Atia, Nora
    Ismail, Amani
    Shady, Abdallah
    Farg, Hashim
    Gabr, Hady
    Fouda, Mohamed
    Abol-Enein, Hassan
    Abdel-Aziz, A. F.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (08) : 1483 - 1490
  • [43] Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4
    Gorbenko, O.
    Panayotou, G.
    Zhyvoloup, A.
    Volkova, D.
    Gout, I.
    Filonenko, V.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2010, 337 (1-2) : 299 - 305
  • [44] Serum fatty acid-binding protein 4 as a biomarker for early detection of diabetic nephropathy in type 2 diabetes
    Shaker, Amr M.
    Mohamed, Maggie E.
    Ramzy, Tarek
    Ali, Mayssa I.
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2023, 35 (01):
  • [45] Serum fatty acid-binding protein 4 as a biomarker for early detection of diabetic nephropathy in type 2 diabetes
    Amr M. Shaker
    Maggie E. Mohamed
    Tarek Ramzy
    Mayssa I. Ali
    The Egyptian Journal of Internal Medicine, 35
  • [46] Novel fatty acid binding protein 4 (FABP4) inhibitors: Virtual screening, synthesis and crystal structure determination
    Cai, Haiyan
    Liu, Qiufeng
    Gao, Dingding
    Wang, Ting
    Chen, Tiantian
    Yan, Guirui
    Chen, Kaixian
    Xu, Yechun
    Wang, Heyao
    Li, Yingxia
    Zhu, Weiliang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 90 : 241 - 250
  • [47] Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury
    Huang, Rongshuang
    Shi, Min
    Guo, Fan
    Feng, Yuying
    Feng, Yanhuan
    Liu, Jing
    Li, Lingzhi
    Liang, Yan
    Xiang, Jin
    Lei, Song
    Ma, Liang
    Fu, Ping
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [48] Common Genetic Variants in Fatty Acid-Binding Protein-4 (FABP4) and Clinical Diabetes Risk in the Women's Health Initiative Observational Study
    Chan, Kei-Hang K.
    Song, Yiqing
    Hsu, Yi-Hsiang
    You, Nai-chieh Y.
    Tinker, Lesley F.
    Liu, Simin
    OBESITY, 2010, 18 (09) : 1812 - 1820
  • [49] Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes
    Ezzat, Eman Mahmoud
    Bakr, Salwa
    Golam, Rehab M.
    Abdelgyed, Basma Atiya
    Nasr, Nourhan Mohamed
    ANNALS OF HEMATOLOGY, 2024, 103 (09) : 3473 - 3482
  • [50] The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients
    Coll, Blai
    Cabre, Anna
    Alonso-Villaverde, Carlos
    Lazaro, Iolanda
    Aragones, Gerard
    Parra, Sandra
    Girona, Josefa
    Masana, Lluis
    ATHEROSCLEROSIS, 2008, 199 (01) : 147 - 153
12345